INNERCAP Technologies Granted Patent Application for Capsular Delivery System
INNERCAP Technologies, Inc., an international drug delivery and specialty pharmaceutical company, recently announced the grant of Canadian Patent Application No. 2,481,486 titled Multi-Phase, Multi-Compartment Capsular Delivery System. The delivery system has uses for biopharmaceutical, pharmaceutical, medical foods, and nutraceutical products. In addition to the existing US, Australian, and New Zealand patents, this new Canadian patent covers the company’s multi-phase multi-compartment capsular delivery system used to enable the development of multi-compartment, multi-phase two-piece capsule delivery forms of advanced combination controlled-release products.
“This is another significant development for INNERCAP Technologies multi-phase, multi-compartment NOVACAP technology,” said Fred H. Miller, Chief Executive Officer at INNERCAP. “The continued growth of our patent portfolio establishes INNERCAP as one of the leading companies in this space in
The delivery system and combinations covered by the patent have the ability to deliver therapeutic entities that have never been combined previously and now can be administered together, via an oral, implanted, or suppository capsule, in the most advantageous pharmacokinetic profile, utilizing different physical phases. This technology can therefore be used to enable capsule administration of compounds that are not normally administered as a combination product. The efficacy, safety, and side-effect profiles of drugs can be substantially improved using this delivery technology. It will also provide very significant quality-of-life improvements for patients and substantial economic savings for hard-pressed healthcare systems.
“INNERCAP’s multi-phase, multi-compartment technology has been commercially manufactured and validated in several products, demonstrating that INNERCAP’s multi-phase capsule delivery system creates real value to consumers and branded manufacturers,” added Mr. Miller.
INNERCAP was represented by Clifford M. Davidson, Esq. of the patent firm Davidson, Davidson & Kappel, LLC based in
Total Page Views: 1172
